Donald W. Paty - Publications

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Neuroscience Biology, Pathology, Molecular Biology

141 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Szasz G, Paty D, Lawton‐Speert S, Eisen K. A Sexual Functioning Scale in multiple sclerosis. Acta Neurologica Scandinavica. 70: 37-43. PMID 6594915 DOI: 10.1111/J.1600-0404.1984.Tb02550.X  0.406
2008 Moore GR, Laule C, Mackay A, Leung E, Li DK, Zhao G, Traboulsee AL, Paty DW. Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss. Journal of Neurology. 255: 1802-11, discussion . PMID 18821049 DOI: 10.1007/S00415-008-0002-Z  0.364
2006 Laule C, Leung E, Lis DK, Traboulsee AL, Paty DW, MacKay AL, Moore GR. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Multiple Sclerosis (Houndmills, Basingstoke, England). 12: 747-53. PMID 17263002 DOI: 10.1177/1352458506070928  0.382
2006 O'Connor PW, Li D, Freedman MS, Bar-Or A, Rice GPA, Confavreux C, Paty DW, Stewart JA, Scheyer R. A phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses Neurology. 66: 894-900. PMID 16567708 DOI: 10.1212/01.Wnl.0000203121.04509.31  0.408
2006 Liu Y, Liu J, Tetzlaff W, Paty DW, Cynader MS. Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis. Free Radical Biology & Medicine. 40: 960-7. PMID 16540391 DOI: 10.1016/J.Freeradbiomed.2005.07.021  0.31
2006 Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, Frank JA, Grossman R, Paty DW, Radue EW, Wolinsky JS. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines American Journal of Neuroradiology. 27: 455-461. PMID 16484429  0.331
2006 Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported Neurology. 66: 172-177. PMID 16434648 DOI: 10.1212/01.Wnl.0000194259.90286.Fe  0.437
2005 Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada Neurology. 65: 1919-1923. PMID 16380613 DOI: 10.1212/01.Wnl.0000188880.17038.1D  0.408
2004 Panitch H, Miller A, Paty D, Weinshenker B. Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study. Neurology. 63: 1788-95. PMID 15557491 DOI: 10.1212/01.Wnl.0000146958.77317.3E  0.368
2004 Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH. Treatment optimization in multiple sclerosis. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 31: 157-68. PMID 15198439 DOI: 10.1017/S0317167100053804  0.381
2004 Petkau AJ, White RA, Ebers GC, Reder AT, Sibley WA, Lublin FD, Paty DW, Duquette P, Girard M, Despault L, DuBois R, Knobler RL, Kelley L, Francis GS, Lapierre Y, et al. Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis Multiple Sclerosis. 10: 126-138. PMID 15124756 DOI: 10.1191/1352458504Ms1004Oa  0.366
2004 Laule C, Vavasour IM, Moore GR, Oger J, Li DK, Paty DW, MacKay AL. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. Journal of Neurology. 251: 284-93. PMID 15015007 DOI: 10.1007/S00415-004-0306-6  0.421
2003 Kastrukoff LF, Lau A, Wee R, Zecchini D, White R, Paty DW. Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity. Journal of Neuroimmunology. 145: 103-14. PMID 14644036 DOI: 10.1016/J.Jneuroim.2003.10.001  0.361
2003 Laule C, Vavasour IM, Whittall KP, Oger J, Paty DW, Li DK, MacKay AL, Arnold DL. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. Journal of Neurology. 250: 924-31. PMID 12928910 DOI: 10.1007/S00415-003-1115-Z  0.421
2003 Liu Y, Zhu B, Wang X, Luo L, Li P, Paty DW, Cynader MS. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. Journal of Neuroimmunology. 139: 27-35. PMID 12799017 DOI: 10.1016/S0165-5728(03)00132-2  0.395
2002 Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: A longitudinal study Neurology. 59: 1006-1010. PMID 12370453 DOI: 10.1212/Wnl.59.7.1006  0.44
2002 Gusev E, Boiko A, Bikova O, Maslova O, Guseva M, Boiko S, Vorobeichik G, Paty D. The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver Clinical Neurology and Neurosurgery. 104: 203-207. PMID 12127655 DOI: 10.1016/S0303-8467(02)00039-2  0.351
2002 Whittall KP, MacKay AL, Li DK, Vavasour IM, Jones CK, Paty DW. Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magnetic Resonance in Medicine. 47: 403-8. PMID 11810687 DOI: 10.1002/Mrm.10076  0.368
2002 Paty DW, Arnold DL. The lesions of multiple sclerosis. The New England Journal of Medicine. 346: 199-200. PMID 11796856 DOI: 10.1056/Nejm200201173460311  0.39
2002 Paty DW. The diagnosis and management of multiple sclerosis: An MRI perspective Acta Neurologica Taiwanica. 11: 1-7.  0.324
2001 Duquette P, Girard M, Despault L, Dubois R, Knobler RL, Lublin FD, Kelley L, Francis GS, Lapierre Y, Antel J, Freedman M, Hum S, Greenstein JI, Mishra B, Muldoon J, ... ... Paty DW, et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology. 57: S3-S9. PMID 11902592  0.301
2001 Paty DW, Li DKB. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology. 57. PMID 11902589  0.321
2001 Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics. 3: 145-51. PMID 11523565 DOI: 10.1007/S100480100113  0.382
2001 McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology. 50: 121-7. PMID 11456302 DOI: 10.1002/Ana.1032  0.487
2001 Liu Y, Zhu B, Luo L, Li P, Paty DW, Cynader MS. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport. 12: 1841-5. PMID 11435909 DOI: 10.1097/00001756-200107030-00016  0.337
2001 Li DKB, Zhao GJ, Paty DW. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results Neurology. 56: 1505-1513. PMID 11402107 DOI: 10.1212/Wnl.56.11.1505  0.385
2001 Paty DW. Multiple Sclerosis in Clinical Practice Jama Neurology. 58: 141-141. DOI: 10.1001/Archneur.58.1.141  0.38
2000 Moore GR, Leung E, MacKay AL, Vavasour IM, Whittall KP, Cover KS, Li DK, Hashimoto SA, Oger J, Sprinkle TJ, Paty DW. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology. 55: 1506-10. PMID 11094105 DOI: 10.1212/Wnl.55.10.1506  0.371
2000 Paty DW. Ultrasound measurement of brain atrophy in multiple sclerosis Archives of Neurology. 57: 1264. PMID 11023451 DOI: 10.1001/Archneur.57.9.1264  0.344
2000 Hintzen RQ, Pot K, Paty D, Oger J. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis. Acta Neurologica Scandinavica. 101: 57-60. DOI: 10.1034/J.1600-0404.2000.00007.X  0.311
2000 Paty DW. AN ATLAS OF MULTIPLE SCLEROSIS. 1998. Edited by Charles Poser. Published by Parthenon Publishing. 129 pages C$101.40 approx. Canadian Journal of Neurological Sciences. 27: 174-174. DOI: 10.1017/S0317167100052331  0.346
1999 Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H, Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis (Houndmills, Basingstoke, England). 5: 251-9. PMID 10467384 DOI: 10.1177/135245859900500410  0.405
1999 Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 53: 448-56. PMID 10449103 DOI: 10.1212/Wnl.53.3.448  0.453
1999 Li DKB, Paty DW. Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing- remitting multiple sclerosis Annals of Neurology. 46: 197-206. PMID 10443885 DOI: 10.1002/1531-8249(199908)46:2<197::Aid-Ana9>3.0.Co;2-P  0.396
1999 Hintzen RQ, Paty D, Oger J. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 66: 791-793. PMID 10329758 DOI: 10.1136/Jnnp.66.6.791  0.401
1999 Rice GPA, Paszner B, Oger J, Lesaux J, Paty D, Ebers G. The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b Neurology. 52: 1277-1277. PMID 10214759 DOI: 10.1212/Wnl.52.6.1277  0.372
1999 Zhu B, Moore GR, Zwimpfer TJ, Kastrukoff LF, Dyer JK, Steeves JD, Paty DW, Cynader MS. Axonal cytoskeleton changes in experimental optic neuritis. Brain Research. 824: 204-17. PMID 10196450 DOI: 10.1016/S0006-8993(99)01191-9  0.326
1999 Cover KS, Petkau J, Li DKB, Paty DW, Filippi M, Sormani MP, Barkhof F, van Waesberghe JH, Gawne-Cain ML, Miller DH, Gasperini C, Grimaud J. Lesion load reproducibility and statistical sensitivity of clinical trials in multiple sclerosis [9] (multiple letters) Neurology. 52: 433-435. PMID 9932990 DOI: 10.1212/Wnl.52.2.433  0.349
1999 Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW. Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B. Neurology. 52: 351-9. PMID 9932956 DOI: 10.1212/Wnl.52.2.351  0.389
1999 Paty DW, Vorobeychik G. Magnetoresonance tomography in multiple sclerosis Zhurnal Nevropatolgii I Psikhiatrii Im. S S Korsakova. 99: 53-57.  0.312
1998 Vavasour IM, Whittall KP, MacKay AL, Li DKB, Vorobeychik G, Paty DW. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients Magnetic Resonance in Medicine. 40: 763-768. PMID 9797161 DOI: 10.1002/Mrm.1910400518  0.398
1998 Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. Journal of Neuroimmunology. 86: 123-33. PMID 9663557 DOI: 10.1016/S0165-5728(98)00014-9  0.411
1998 Filippi M, Horsfield MA, Adèr HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis Annals of Neurology. 43: 499-506. PMID 9546332 DOI: 10.1002/Ana.410430414  0.43
1998 Hockertz MK, Paty DW, Beall SS. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR β locus: Use of affected family-based controls American Journal of Human Genetics. 62: 373-385. PMID 9463308 DOI: 10.1086/301700  0.436
1998 Kastrukoff LF, Morgan NG, Zecchini D, Paty DW. A role for CD16+ CD57+ natural killer (NK) cells in the immunopathogenesis of multiple sclerosis (MS) Journal of Neuroimmunology. 90: 74. DOI: 10.1016/S0165-5728(98)91622-8  0.354
1998 Hintzen RQ, Paty D, Oger JJF. Cerebrospinal fluid levels of soluble CD27 correlate with disease activity in multiple sclerosis and with disease state in HTLV-1 associated HAM/TSP Journal of Neuroimmunology. 90: 66. DOI: 10.1016/S0165-5728(98)91576-4  0.316
1997 Paty DW. MRI as a method to reveal in-vivo pathology in MS Journal of Neural Transmission, Supplement. 211-217. PMID 9266430  0.35
1997 Clark CM, Jacova C, Klonoff H, Kremer B, Hayden M, Paty D. Pathological association and dissociation of functional systems in multiple sclerosis and Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 19: 63-76. PMID 9071642 DOI: 10.1080/01688639708403837  0.333
1997 Zhao GJ, Li DKB, Wolinsky JS, Koopmans RA, Mietlowski W, Redekop WK, Riddehough A, Cover K, Paty DW. Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis Journal of Neuroimaging. 7: 1-7. PMID 9038425 DOI: 10.1111/Jon1997711  0.403
1997 Whittall KP, MacKay AL, Graeb DA, Nugent RA, Li DKB, Paty DW. In vivo measurement of T2 distributions and water contents in normal human brain Magnetic Resonance in Medicine. 37: 34-43. PMID 8978630 DOI: 10.1002/Mrm.1910370107  0.327
1997 Oger J, Vorobeychick G, Paty DW. IGG secretion in vitro in relation with antibody status in MS patients treated with interferon beta 1B Multiple Sclerosis. 3: 406. DOI: 10.1177/135245859700300617  0.379
1996 Paty DW, Goodkin D, Thompson A, Rice G. Guidelines for physicians with patients on IFNβ-1b: The use of an assay for neutralizing antibodies (NAB) Neurology. 47: 865-866. PMID 8857709 DOI: 10.1212/Wnl.47.4.865  0.307
1996 Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW. Depression and multiple sclerosis Neurology. 46: 628-632. PMID 8618657 DOI: 10.1212/Wnl.46.3.628  0.335
1996 Rolak LA, Beck RW, Paty DW, Tourtellotte WW, Whitaker JN, Rudick RA. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology. 46: 368-72. PMID 8614496 DOI: 10.1212/Wnl.46.2.368  0.385
1996 Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Annals of Neurology. 39: 6-16. PMID 8572668 DOI: 10.1002/Ana.410390104  0.471
1996 Sibley WA, Paty D, Ebers G, Reder A, Lublin F. Reply from the Authors to Drs. Milanese, Savettieri, and Terizan: IFNB in MS Neurology. 47: 1112-1112. DOI: 10.1212/Wnl.47.4.1112  0.354
1996 Li DKB, Paty DW, Koopmans RA, Zhao G. The effects of interferon beta-lb in multiple sclerosis as assessed by MRI Clinical Immunotherapeutics. 5: 47-54.  0.357
1995 Sandberg-Wollheim M, Hommes OR, Hughes RA, Paty DW, Abdul-Ahad AK. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis Multiple Sclerosis (Houndmills, Basingstoke, England). 1. PMID 9345399  0.302
1995 Confaveux C, Paty DW, Confavreux C, Aimard G, Devic M, Weinshenker BG, Bass B, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC, Lee KH, Hashimoto HA, Hooge JP, et al. Current status of computerization of multiple sclerosis clinical data for research in europe and north america: The edmus/ms-costar connection Neurology. 45: 573-576. PMID 7898721 DOI: 10.1212/Wnl.45.3.573  0.309
1995 Filippi M, Paty DW, Kappos L, Barkhof F, Compston D, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Correlations between changes in disability and T<inf>2</inf>-weighted brain mri activity in multiple sclerosis: A follow-up study Neurology. 45: 255-260. PMID 7854522 DOI: 10.1212/Wnl.45.2.255  0.45
1995 EbersS GC, Sibley WA, Paty DW. Immunotherapy for MS: clinical aspects and trials Acta Neurologica Scandinavica. 91: 54-54. PMID 7653246 DOI: 10.1111/J.1600-0404.1995.Tb05857.X  0.418
1995 Whitaker JN, Kachelhofer RD, Bradley EL, Burgard S, Layton BA, Reder AT, Morrison W, Zhao GJ, Paty DW. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Annals of Neurology. 38: 625-32. PMID 7574459 DOI: 10.1002/Ana.410380411  0.484
1995 Kastrukoff L, Morgan N, Zecchini D, Satoh J, Paty D. Correlation of natural killer (NK) cell functional activity and phenotype with disease activity determined clinically and by serial MRIs. Effect on interferon-Beta-1b Journal of Neuroimmunology. 56: 64-64. DOI: 10.1016/0165-5728(95)99083-U  0.306
1994 Kupersmith MJ, Kaufman D, Paty DW, Ebers G, Mc Farland H, Johnson K, Reingold S, Whitaker J. Megadose corticosteroids in multiple sclerosis Neurology. 44: 1-4. PMID 8290041 DOI: 10.1212/Wnl.44.1.1  0.47
1994 Mackay A, Whittall K, Adler J, Li D, Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance Magnetic Resonance in Medicine. 31: 673-677. PMID 8057820 DOI: 10.1002/Mrm.1910310614  0.334
1994 Paty D, Studney D, Redekop K, Lublin F. MS COSTAR : a computerized patient record adapted for clinical research purposes Annals of Neurology. 36. PMID 8017875 DOI: 10.1002/Ana.410360732  0.442
1994 Paty DW. The interferon-β1b clinical trial and its implications for other trials Annals of Neurology. 36. PMID 8017869 DOI: 10.1002/Ana.410360726  0.322
1994 Sadovnick AD, Eisen K, Hashimoto SA, Farquhar R, Hooge J, Kastrukoff L, Oger JJF, Paty DW, Yee IML. Pregnancy and multiple sclerosis: A prospective study Archives of Neurology. 51: 1120-1124. PMID 7980107 DOI: 10.1001/Archneur.1994.00540230058013  0.441
1994 Whitaker JN, Williams PH, Layton BA, McFarland HF, Stone LA, Smith ME, David Kachelhofer R, Bradley EL, Burgard S, Zhao G, Paty DW. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis Annals of Neurology. 35: 577-585. PMID 7513981 DOI: 10.1002/ana.410350511  0.388
1993 Koopmans RA, Li DK, Redekop WK, Zhao GJ, Palmer MR, Kastrukoff LF, Paty DW. The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 3: 163-8. PMID 10146223 DOI: 10.1111/Jon199333163  0.41
1993 Stewart WA, MacKay AL, Whittall KP, Moore GR, Paty DW. Spin-spin relaxation in experimental allergic encephalomyelitis. Analysis of CPMG data using a non-linear least squares method and linear inverse theory. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 29: 767-75. PMID 8350719 DOI: 10.1002/Mrm.1910290608  0.371
1993 Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. The New England Journal of Medicine. 329: 1764-9. PMID 8232485 DOI: 10.1056/Nejm199312093292403  0.352
1993 Studney D, Lublin F, Marcucci L, Farquhar R, Redekop K, Nelson J, Paty DW. MS COSTAR: A Computerized Record for Use in Clinical Research in Multiple Sclerosis: Neurorehabilitation and Neural Repair. 7: 145-152. DOI: 10.1177/136140969300700309  0.452
1993 Paty DW, Koopmans RA, Zhao G, Li DKB, Oger JJF, Petkau J. Magnetic Resonance Imaging (MRI) As an Outcome Measure in Multiple Sclerosis Neurorehabilitation and Neural Repair. 7: 117-129. DOI: 10.1177/136140969300700306  0.337
1992 Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Archives of Neurology. 49: 641-3. PMID 1596200 DOI: 10.1001/Archneur.1992.00530300077013  0.305
1992 Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Life expectancy in patients attending multiple sclerosis clinics Neurology. 42: 991-994. PMID 1579256 DOI: 10.1212/Wnl.42.5.991  0.452
1992 Paty DW. Magnetic resonance imaging in the diagnosis and follow-up of patients with multiple sclerosis Italian Journal of Neurological Sciences. 13: 125-131. PMID 1345733  0.358
1992 Clark CM, James G, Li D, Oger J, Paty D, Klonoff H. Ventricular size, cognitive function and depression in patients with multiple sclerosis. Canadian Journal of Neurological Sciences. 19: 352-356. DOI: 10.1017/S0317167100041986  0.352
1991 Lee KH, Hashimoto SA, Hooge JP, Kastrukoff LF, Oger JJF, Li DKB, Paty DW. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT Neurology. 41: 657-660. PMID 2027480 DOI: 10.1212/Wnl.41.5.657  0.473
1991 Klonoff H, Clark C, Oger J, Paty D, Li D. Neuropsychological performance in patients with mild multiple sclerosis. Journal of Nervous and Mental Disease. 179: 127-131. PMID 1997658 DOI: 10.1097/00005053-199103000-00002  0.388
1991 Paty DW, McFarlin DE, McDonald WI. Magnetic resonance imaging and laboratory aids in the diagnosis of multiple sclerosis Annals of Neurology. 29: 3-5. PMID 1996877 DOI: 10.1002/Ana.410290103  0.335
1991 Boyle EA, Clark CM, Klonoff H, Paty DW, Oger J. Empirical Support for Psychological Profiles Observed in Multiple Sclerosis Archives of Neurology. 48: 1150-1154. PMID 1953400 DOI: 10.1001/Archneur.1991.00530230058022  0.37
1991 Sadovnick AD, Eisen K, Ebers G, Paty DW. Cause of death in patients attending multiple sclerosis clinics Neurology. 41: 1193-1196. PMID 1866003 DOI: 10.1212/Wnl.41.8.1193  0.384
1991 Kastrukoff LF, Oger JJ, Tourtellotte WW, Sacks SL, Berkowitz J, Paty DW. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation. Neurology. 41: 1936-41. PMID 1745353 DOI: 10.1212/Wnl.41.12.1936  0.39
1990 Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, Koopmans RA, Petkau AJ, Berkowitz J, Paty DW. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology. 40: 479-86. PMID 2179764 DOI: 10.1212/Wnl.40.3_Part_1.479  0.433
1990 Boylan KB, Takahashi N, Paty DW, Sadovnick AD, Diamond M, Hood LE, Prusiner SB. DNA length polymorphism 5' to the myelin basic protein gene is associated with multiple sclerosis. Annals of Neurology. 27: 291-7. PMID 1691612 DOI: 10.1002/Ana.410270311  0.385
1989 Koopmans RA, Li DKB, Grochowski E, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features Annals of Neurology. 25: 74-81. PMID 2913931 DOI: 10.1002/Ana.410250112  0.465
1989 Willoughby EW, Grochowski E, Li DKB, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients Annals of Neurology. 25: 43-49. PMID 2913928 DOI: 10.1002/ana.410250107  0.38
1989 Koopmans RA, Li DKB, Oger JJF, Kastrukoff LF, Jardine C, Costley L, Hall S, Grochowski EW, Paty DW. Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months Annals of Neurology. 26: 248-256. PMID 2774512 DOI: 10.1002/ana.410260211  0.34
1989 Weiner HL, Paty DW. Diagnostic and therapeutic trials in multiple sclerosis: A new look summary of Jekyll Island workshop Neurology. 39: 972-976. PMID 2662054 DOI: 10.1212/Wnl.39.7.972  0.389
1989 Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JJ, Eisen AA, Eisen KA, Purves SJ, Low M, Brandjes V, Robertson W, Li D. Biologic versus clinical MS Neurology. 39: 151. PMID 2642612 DOI: 10.1212/Wnl.39.1.151  0.444
1989 Paty DW. Multiple sclerosis Current Opinion in Neurology and Neurosurgery. 2: 175-178. DOI: 10.1016/S0011-5029(86)80013-X  0.371
1989 Paty DW. Response to the reply: Biologic versus clinical MS Neurology. 39: 153.  0.316
1989 Paty DW, Willoughby EW, Koopmans RA, Oger JFJ, Li DKB. Magnetic resonance imaging (MRI) as a tool for the assessment of disease activity in multiple sclerosis (MS) Multiple Sclerosis Research: Proceedings of the International Multiple Sclerosis Conference: An Update On Multiple Sclerosis. Ics843. 97-104.  0.328
1988 Isaac C, Li DKB, Genton M, Jardine C, Grochowski E, Palmer M, Kastrukoff LF, Oger J, Paty DW. Multiple sclerosis: A serial study using MRI in relapsing patients Neurology. 38: 1511-1515. PMID 3419593 DOI: 10.1212/Wnl.38.10.1511  0.458
1988 Paty DW, Oger JJF, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V, Robertson WD, Li DKB. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT Neurology. 38: 180-185. PMID 3340277 DOI: 10.1212/Wnl.38.2.180  0.479
1988 Paty DW. Magnetic Resonance Imaging in the Assessment of Disease Activity in Multiple Sclerosis Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 15: 266-272. PMID 3208208 DOI: 10.1017/S0317167100027724  0.338
1988 Oger J, Kastrukoff LF, Li DKB, Paty DW. Multiple sclerosis:In relapsing patients, immune functions vary with disease activity as assessed by mri Neurology. 38: 1739-1744. PMID 3185908 DOI: 10.1212/Wnl.38.11.1739  0.415
1988 Kastrukoff LF, Morgan NG, Aziz TM, Zecchini D, Berkowitz J, Paty DW. Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon Journal of Neuroimmunology. 20: 15-23. PMID 3183034 DOI: 10.1016/0165-5728(88)90109-9  0.384
1988 Oger J, O'Gorman M, Willoughby E, Li D, Paty DW. Changes in immune function in relapsing multiple sclerosis correlate with disease activity as assessed by magnetic resonance imaging Annals of the New York Academy of Sciences. 540: 597-601. PMID 2974690 DOI: 10.1111/J.1749-6632.1988.Tb27185.X  0.362
1987 Honer WG, Hurwitz T, Li DKB, Palmer M, Paty DW. Temporal Lobe Involvement in Multiple Sclerosis Patients With Psychiatric Disorders Archives of Neurology. 44: 187-190. PMID 3813935 DOI: 10.1001/Archneur.1987.00520140053017  0.458
1987 Duquette P, Murray TJ, Pleines J, Ebers GC, Sadovnick D, Weldon P, Warren S, Paty DW, Upton A, Hader W. Multiple sclerosis in childhood: clinical profile in 125 patients. The Journal of Pediatrics. 111: 359-63. PMID 3625402 DOI: 10.1016/S0022-3476(87)80454-7  0.467
1987 Eisen A, Odusote K, Li D, Robertson W, Purvis S, Eisen K, Paty D. Comparison of magnetic resonance imaging with somatosensory testing in MS suspects. Muscle & Nerve. 10: 385-390. PMID 3614252 DOI: 10.1002/Mus.880100502  0.467
1987 Paty DW. Multiple sclerosis: Assessment of disease progression and effects of treatment Canadian Journal of Neurological Sciences. 14: 518-520. PMID 3315154  0.321
1987 Robertson WD, Li DK, Mayo JR, Fache JS, Paty DW. Assessment of multiple sclerosis lesions by magnetic resonance imaging. Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes. 38: 177-82. PMID 2958465  0.318
1987 Oger J, Willoughby E, Paty DW. Immune function in MS: Correlation with disease activity as revealed by MRI Journal of Neuroimmunology. 16: 134. DOI: 10.1016/0165-5728(87)90337-7  0.422
1987 Asbury AK, Herndon RM, McFarland HF, McDonald WI, McIlroy WJ, Paty DW, Prineas JW, Scheinberg LC, Wolinsky JS. National Multiple Sclerosis Society Working Group on Neuroimaging for the Medical Advisory Board Neuroradiology. 29: 119. DOI: 10.1007/Bf00327534  0.316
1987 Paty DW. MRI in MS diagnosis: Reply from the author Neurology. 37: 1566-1567.  0.325
1986 Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T. A population-based study of multiple sclerosis in twins. The New England Journal of Medicine. 315: 1638-42. PMID 3785335 DOI: 10.1056/Nejm198612253152603  0.436
1986 Oger J, Kastrukoff L, O'Gorman M, Paty DW. Progressive multiple sclerosis: Abnormal immune functions in vitro and aberrant correlation with enumeration of lymphocyte subpopulations Journal of Neuroimmunology. 12: 37-48. PMID 2940262 DOI: 10.1016/0165-5728(86)90095-0  0.467
1986 Rice GP, Armstrong HA, Bulman DE, Paty DW, Ebers GC. Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy. Annals of Neurology. 20: 533-4. PMID 2878638 DOI: 10.1002/Ana.410200415  0.4
1985 Paty DW. Book ReviewMcAlpine's Multiple Sclerosis The New England Journal of Medicine. 313: 899-899. DOI: 10.1056/Nejm198510033131426  0.394
1984 Szasz G, Paty D, Maurice WL. Sexual Dysfunctions in Multiple Sclerosis Annals of the New York Academy of Sciences. 436: 443-452. PMID 6598022 DOI: 10.1111/J.1749-6632.1984.Tb14817.X  0.359
1984 LaRocca NG, Scheinberg LC, Slater RJ, Giesser B, Smith CR, Traugott U, Schapiro RT, Paty DW, Franklin GM, Cobble N. Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada. Acta Neurologica Scandinavica. Supplementum. 101: 126-38. PMID 6594902 DOI: 10.1111/J.1600-0404.1984.Tb02563.X  0.431
1984 Kastrukoff LF, Paty DW. A two-label microfluorometric analysis of the expression of OKT5 and Leu 2a antigens on peripheral blood lymphocytes in patients with multiple sclerosis Journal of Neuroimmunology. 6: 85-92. PMID 6547149 DOI: 10.1016/0165-5728(84)90029-8  0.385
1984 Noseworthy JH, Paty DW, Ebers GC. Neuroimaging in multiple sclerosis Neurologic Clinics. 2: 759-777. PMID 6521718 DOI: 10.1016/S0733-8619(18)31073-9  0.389
1984 Dworkin RH, Bates D, Millar JHD, Paty DW. Linoleic acid and multiple sclerosis: A reanalysis of three double-blind trials Neurology. 34: 1441-1445. PMID 6387534 DOI: 10.1212/Wnl.34.11.1441  0.422
1984 PATY DW, KASTRUKOFF LF. Suppressor T Cells in MS: Do Changes in Numbers Vary with Clinical Activity? Annals of the New York Academy of Sciences. 436: 266-270. PMID 6241818 DOI: 10.1111/J.1749-6632.1984.Tb14798.X  0.41
1984 Kastrukoff LF, Paty DW. A serial study of peripheral blood T lymphocyte subsets in relapsing–remitting multiple sclerosis Annals of Neurology. 15: 250-256. PMID 6232891 DOI: 10.1002/Ana.410150308  0.335
1984 Li D, Mayo J, Fache S, Robertson WD, Paty D, Genton M. Early Experience in Nuclear Magnetic Resonance Imaging of Multiple Sclerosis Annals of the New York Academy of Sciences. 436: 483-486. DOI: 10.1111/J.1749-6632.1984.Tb14825.X  0.329
1983 Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology. 13: 227-31. PMID 6847134 DOI: 10.1002/Ana.410130302  0.345
1983 Moulin D, Paty DW, Ebers GC. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis Brain. 106: 809-816. PMID 6652464 DOI: 10.1093/Brain/106.4.809  0.379
1983 Paty DW, Davis FA. Patient selection and criteria. Archives of Neurology. 40: 701. PMID 6625979 DOI: 10.1001/Archneur.1983.04050100041015  0.45
1983 Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G. Multiple sclerosis after age 50 Neurology. 33: 1537-1537. PMID 6606140 DOI: 10.1212/Wnl.33.12.1537  0.463
1983 Paty DW. Double-blind Trial of Linoleic Acid in Multiple Sclerosis Archives of Neurology. 40: 693-694. PMID 6354153 DOI: 10.1001/Archneur.1983.04050100033011  0.416
1983 Paty DW, Kastrukoff L, Morgan N, Hiob L. Suppressor T‐lymphocytes in multiple sclerosis: Analysis of patients with acute relapsing and chronic progressive disease Annals of Neurology. 14: 445-449. PMID 6227277 DOI: 10.1002/Ana.410140408  0.403
1982 Brett DC, Ferguson GG, Ebers GC, Paty DW. Percutaneous Trigeminal Rhizotomy: Treatment of Trigeminal Neuralgia Secondary to Multiple Sclerosis Archives of Neurology. 39: 219-221. PMID 6978703 DOI: 10.1001/Archneur.1982.00510160025004  0.348
1982 Eisen A, Paty D, Hoirch M. Altered supernormality in multiple sclerosis peripheral nerve Muscle & Nerve. 5: 411-414. PMID 6289099 DOI: 10.1002/Mus.880050513  0.351
1981 Feasby TE, Paty DW, Ebers GC, Fox AJ. Spinal Cord Swelling in Multiple Sclerosis Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 8: 151-153. PMID 7296423 DOI: 10.1017/S0317167100043079  0.34
1981 Eisen A, Paty D, Purves S, Hoirch M. Occult fifth nerve dysfunction in multiple sclerosis. Canadian Journal of Neurological Sciences. 8: 221-225. PMID 7284899 DOI: 10.1017/S0317167100043249  0.37
1981 Ebers GC, Cousin HK, Feasby TE, Paty DW. Optic neuritis in familial MS Neurology. 31: 1138-1142. PMID 7196536 DOI: 10.1212/Wnl.31.9.1138  0.35
1981 Sibley WA, Paty DW. A comparison of multiple sclerosis in arizona (usa) and ontario (Canada) - Preliminary report Acta Neurologica Scandinavica. 64: 60-65. DOI: 10.1111/j.1600-0404.1981.tb05531.x  0.327
1981 Dales S, Ebers G, Feasby T, Paty D. Conference Report: International Symposium on Multiple Sclerosis University of Western Ontario May 3-5, 1981 Canadian Journal of Neurological Sciences. 8: 333-338. DOI: 10.1017/S031716710004347X  0.405
1980 Ebers GC, Paty DW. CSF Electrophoresis in One Thousand Patients Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 7: 275-280. PMID 7011523 DOI: 10.1017/S0317167100022733  0.306
1979 Paty DW, Blume WT, Brown WF, Jaatoul N, Kertesz A, McLnnis W. Chronic progressive myelopathy: Investigation with CSF electrophoresis, evoked potentials, and CT scan Annals of Neurology. 6: 419-424. PMID 92910 DOI: 10.1002/ana.410060508  0.31
1978 Paty DW, Cousin HK, Stiller CR, Dossetor JB. An HLA-D-linked low response to polyclonal B-cell activation in multiple sclerosis Transplantation Proceedings. 10: 973-975. PMID 366836  0.313
1977 Paty DW, Dossetor JB, Stiller CR, Cousin HK, Marchuk L, Furesz J, Boucher DW. Hla in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course Journal of the Neurological Sciences. 32: 371-379. PMID 886362 DOI: 10.1016/0022-510X(77)90020-X  0.301
1976 Warren KG, Paty DW, McFarlane SA, Warren SA. Letter: Herpes labialis and multiple sclerosis. Lancet (London, England). 1: 1193. PMID 58249  0.363
1976 Warren KG, Paty DW, Mcfarlane M, Warren SA. HERPES LABIALIS AND MULTIPLE SCLEROSIS The Lancet. 307: 1193. DOI: 10.1016/S0140-6736(76)91595-6  0.367
1974 Spoerel WE, Paty DW, Kertesz A, Leung CY. Letter: Acupuncture and multiple sclerosis Canadian Medical Association Journal. 110: 751. PMID 4825139  0.364
1971 Kibler RF, Paty DW, Sherr V. Immunology of multiple sclerosis Research Publications - Association For Research in Nervous and Mental Disease. 49: 95-111. PMID 5133707  0.373
Show low-probability matches.